News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 18, 2016, 07:00 ET Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016

Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its third quarter 2016 financial results before the open of the U.S. financial markets on November 8, 2016 and members of its senior...


Sep 30, 2016, 07:30 ET Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced new data to be presented evaluating the safety and efficacy of XIAFLEX®(collagenase...


Sep 23, 2016, 07:00 ET Endo Names Paul Campanelli President and Chief Executive Officer

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that its Board of Directors has named Paul V. Campanelli President and Chief Executive Officer, effective immediately. Mr. Campanelli...


Aug 18, 2016, 16:05 ET Endo's President and CEO Adopts 10b5-1 Trading Plan

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that Rajiv De Silva, President and CEO, has entered into a Rule 10b5-1 stock trading plan in connection with his year-end tax planning....


Aug 12, 2016, 07:00 ET Endo Announces OPANA® ER Regulatory Update

Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that based on an August 11, 2016 discussion with the U.S. Food and Drug Administration (FDA), the Company has decided to withdraw its...


Aug 08, 2016, 16:28 ET Endo Reports Second Quarter 2016 Financial Results

Second quarter 2016 reported revenues of $921 million and diluted GAAP earnings per share (EPS) from continuing operations of $1.75 Second quarter 2016 adjusted diluted EPS of $0.86 Company affirms...


Aug 08, 2016, 16:05 ET Endo Announces Appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals

Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today the appointment of Joseph J. Ciaffoni as President, U.S. Branded Pharmaceuticals, effective August 15, 2016. "We are excited to...


Jul 18, 2016, 07:30 ET Endo to Announce Second Quarter 2016 Financial Results on August 8, 2016

Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its second quarter 2016 financial results after the close of the U.S. financial markets on August 8, 2016 and members of its senior...


Jun 28, 2016, 12:30 ET Endo Announces Issuance of Vasostrict® Patent

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that one of its operating companies, Par Pharmaceutical, has been issued a new patent by the U.S. Patent and Trademark Office (PTO)...


Jun 15, 2016, 08:30 ET Endo Announces FDA Advisory Committee Meeting For OPANA® ER

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced that, based on discussions with the U.S. Food and Drug Administration (FDA), the Company...


Jun 03, 2016, 08:00 ET New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced new data to be presented supporting the safety and tolerability of BELBUCA™...


May 25, 2016, 08:00 ET Endo Employees Participate in 3rd Annual "Endo Gives" Day of Volunteering, Giving Back to Local Communities Around the World

Employees of Endo International plc (NASDAQ: ENDP) (TSX: ENL) are joining together today to donate their workday to assist and support organizations that provide benefit to those in need in Endo's...


May 05, 2016, 16:05 ET Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of Directors

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Douglas S. Ingram, former president of Allergan, Inc. and current CEO of Chase Pharmaceuticals Corporation, and...


May 05, 2016, 16:05 ET Endo Reports First Quarter 2016 Financial Results

First quarter 2016 adjusted diluted earnings per share (EPS) of $1.08 and revenues of $964 million First quarter reported diluted (GAAP) loss per share from continuing operations of $0.40 Company...


May 05, 2016, 16:05 ET Endo Announces Change to Senior Management Team

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that Brian Lortie, President, U.S. Branded Pharmaceuticals, has decided to step down from his position upon the appointment of a...


May 03, 2016, 08:00 ET Endo Announces Appearances at Upcoming Conferences

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that Rajiv De Silva, President and CEO, will present a corporate overview at the 2016 Bank of America Merrill Lynch Health Care...


May 02, 2016, 08:00 ET Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that the U.S. District Court for the Southern District of New York has issued an order upholding its August 2015 ruling in Endo's...


Apr 22, 2016, 08:00 ET Endo to Announce First Quarter 2016 Financial Results on May 5, 2016

Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its first quarter 2016 financial results after the close of the U.S. financial markets on May 5, 2016 and members of its senior...


Mar 21, 2016, 10:34 ET Endo Provides Statement Regarding Expected FDA Approval Of Generic Voltaren® Gel Product

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today provided a statement and a Frequently Asked Questions (FAQs) document regarding the expected approval by the U.S. Food and Drug Administration...


Mar 10, 2016, 08:30 ET Endo Announces Presentation at Barclays Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that Rajiv De Silva, President and CEO, will present a corporate overview at the Barclays Global Healthcare Conference on Thursday,...


Mar 09, 2016, 06:00 ET National Sports Commentator, Dr. Jerry Punch, Together with Men's Health Network and Endo Pharmaceuticals, Encourages Men with Peyronie's Disease to Ask About the Curve

Nationally-recognized and long-standing sports announcer Jerry Punch, M.D., is teaming up with Men's Health Network and Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ:...


Mar 02, 2016, 07:15 ET Endo Provides Informational Frequently Asked Questions & Answers

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that it has provided an informational Frequently Asked Questions (FAQs) document designed for investors to learn more about the...


Feb 29, 2016, 06:30 ET Endo Reports Fourth Quarter And Full Year 2015 Financial Results

Full year 2015 adjusted diluted EPS of $4.66 exceeds top end of guidance Fourth quarter revenues of $1,074 million brings full year revenues to top end of guidance Fourth quarter reported $1.97...


Feb 22, 2016, 07:30 ET Endo Announces Launch Of BELBUCA™ (Buprenorphine) Buccal Film For Chronic Pain Management

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced the availability of BELBUCA™ (buprenorphine) buccal film, the first and only buprenorphine ...


Feb 17, 2016, 09:00 ET Endo Announces Initiation of Phase 2B Clinical Trial of Collagenase Clostridium Histolyticum in Cellulite

Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the initiation of its Phase 2b study of collagenase clostridium histolyticum (or "CCH") for the treatment of edematous fibrosclerotic...